XYLONOR solution for oromucosal spray 150mg/1.5mg per g
Product details
Registration number: SIN07224P
Classification: Pharmacy Only
Active ingredients:
- CETRIMIDE
- LIGNOCAINE
Strength:
- 0.15 g/100 g
- 15 g/100 g
Dosage form: SPRAY
Route: BUCCAL
Registrant: N.K. LUCK (S) PTE LTD
ATC code: D04AB
HSA approval date: 25 September 1992
Manufacturer(s): SEPTODONT
Manufacturing country/countries: FRANCE
What are the HSA registration number and classification for XYLONOR solution for oromucosal spray 150mg/1.5mg per g?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN07224P
Classification: Pharmacy Only
What active ingredients and strength are recorded for XYLONOR solution for oromucosal spray 150mg/1.5mg per g?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CETRIMIDE
- LIGNOCAINE
Strength:
- 0.15 g/100 g
- 15 g/100 g
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for XYLONOR solution for oromucosal spray 150mg/1.5mg per g?
According to the HSA dataset updated 7 August 2026:
Dosage form: SPRAY
Route: BUCCAL
Who is the recorded registrant for XYLONOR solution for oromucosal spray 150mg/1.5mg per g?
According to the HSA dataset updated 7 August 2026:
Registrant: N.K. LUCK (S) PTE LTD
Which manufacturers and countries are listed for XYLONOR solution for oromucosal spray 150mg/1.5mg per g?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): SEPTODONT
Manufacturing country/countries: FRANCE
Where can I look up XYLONOR solution for oromucosal spray 150mg/1.5mg per g in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN07224P or the exact product name XYLONOR solution for oromucosal spray 150mg/1.5mg per g. The general register link does not preselect this product.
What are the source dates for this XYLONOR solution for oromucosal spray 150mg/1.5mg per g record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this XYLONOR solution for oromucosal spray 150mg/1.5mg per g record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN07224P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)